This paper is in the following e-collection/theme issue:

Recruitment of Research Participants (296) Dementia and Cognitive Decline (482) Cost-Effectiveness and Economics (252) Innovations in Clinical Trials and Research Data Management (83)

Published on in Vol 23, No 7 (2021): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26284, first published .
Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study

Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study

Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study

Authors of this article:

Kenichiro Sato1, 2 Author Orcid Image ;   Yoshiki Niimi3 Author Orcid Image ;   Ryoko Ihara4 Author Orcid Image ;   Kazushi Suzuki5 Author Orcid Image ;   Tatsushi Toda1 Author Orcid Image ;   Atsushi Iwata4 Author Orcid Image ;   Takeshi Iwatsubo2 Author Orcid Image
Article Authors Cited by (4) Tweetations (3) Metrics

Journals

  1. Jimenez-Maggiora G, Bruschi S, Qiu H, So J, Aisen P. ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials. JAMIA Open 2022;5(1) View
  2. Aisen P, Jimenez-Maggiora G, Rafii M, Walter S, Raman R. Early-stage Alzheimer disease: getting trial-ready. Nature Reviews Neurology 2022;18(7):389 View
  3. Hussein A, Moullin J, Hughes J, Stafford A. Researching Pain in People Living with Dementia: Barriers and Potential Solutions. Ageing International 2024;49(2):293 View
  4. Sato K, Niimi Y, Ihara R, Iwata A, Suzuki K, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Awata S, Iwatsubo T. Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan. Alzheimer's Research & Therapy 2024;16(1) View